microRNA-21 Expression as Prognostic and Therapeutic Response Marker in Chronic Myeloid Leukaemia Patients

BACKGROUND: Chronic myeloid leukaemia (CML) is a myeloproliferative disorder categorized by malignant transformation of a single stem cell of hematopoietic cells. microRNAs (miRNAs) belong to transcription regulators in hematopoiesis and their altered expression associates with pathogenesis of CML....

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Asian Pac J Cancer Prev
Autors principals: Beg Mirza, Masroor Ali, Guru, Sameer Ahmad, Abdullah, Saleh Mohammed, Rizvi, Aliya, Saxena, Alpana
Format: Artigo
Idioma:Inglês
Publicat: West Asia Organization for Cancer Prevention 2019
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6852824/
https://ncbi.nlm.nih.gov/pubmed/31450909
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.31557/APJCP.2019.20.8.2379
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars